37.51
Bruker Corp (BRKR) 最新ニュース
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook - AlphaStreet News
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $50 - 富途牛牛
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... - Yahoo Finance
Bruker (NASDAQ:BRKR) Announces Earnings Results - MarketBeat
Why Bruker (BRKR) Stock Is Trading Lower Today - Finviz
Bruker Q4 2025 slides reveal organic decline, stock drops 14% despite FY 2026 optimism - Investing.com
Earnings call transcript: Bruker Q4 2025 earnings miss, stock drops 14% - Investing.com
Bruker: Q4 Financial Results Overview - Bitget
Bruker (BRKR) Q4 Earnings Miss Estimates - Yahoo Finance
Bruker: Q4 Earnings Snapshot - kare11.com
Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates - Yahoo Finance
Bruker earnings missed by $0.06, revenue topped estimates - Investing.com
Bruker Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Bruker Earnings Review: Q4 Summary - Benzinga
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance
Bruker earnings up next: Can momentum continue after Q3 beat? - Investing.com
A Glimpse of Bruker's Earnings Potential - Benzinga
Candriam S.C.A. Cuts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation Announces the Launch of iNTApharma - marketscreener.com
Bruker (BRKR) Launches iNTApharma for Advanced Bioparticle Analy - GuruFocus
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - ChartMill
Bruker Announces Quarterly Preferred Stock Dividend - 富途牛牛
Old West Investment Management LLC Buys 338,618 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker to pay $3.9844 per share to preferred holders Mar. 2 - Stock Titan
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Finviz
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast - marketscreener.com
Investors get Feb. 12 date for Bruker Q4 2025 earnings call - Stock Titan
Bruker (BRKR) to Release Quarterly Earnings on Thursday - MarketBeat
New York State Common Retirement Fund Has $12.05 Million Stake in Bruker Corporation $BRKR - MarketBeat
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛
Guggenheim Raises Price Target for Bruker Corporation (BRKR) - Finviz
Will Bruker Corporation outperform its industry peersGDP Growth & Proven Capital Preservation Tips - Mfd.ru
Levels Update: Will Bruker Corporation stock recover after earningsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Eclipse Bioinnovations, Inc. acquired Terrain Biosciences, Inc. from Magnetic Ventures and Bruker Corporation. - marketscreener.com
Bruker Corp (BRKR) Shares Down 2.98% on Jan 26 - GuruFocus
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $58 - 富途牛牛
Stocks To Watch: Bruker Sees Relative Strength Rating Rise To 82 - Investor's Business Daily
Bruker Corporation (BRKR): A Bull Case Theory - Finviz
TOFWERK joins Bruker: From partnership to full ownership - MSN
Revenues Working Against Bruker Corporation's (NASDAQ:BRKR) Share Price - 富途资讯
SG Americas Securities LLC Has $1.37 Million Stake in Bruker Corporation $BRKR - MarketBeat
Assessing Bruker (BRKR) Valuation After Recent Share Price Rebound And Conflicting Fair Value Signals - Yahoo Finance
Bruker (NASDAQ:BRKR) VP Sells $98,400.00 in Stock - MarketBeat
Citigroup Boosts Bruker (BRKR) Price Target, Maintains Neutral R - GuruFocus
Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $53 - 富途资讯
September 18th Options Now Available For Bruker (BRKR) - Nasdaq
Mark Munch Sells 7,000 Shares of Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker (NASDAQ:BRKR) Stock Price Down 5.8%Should You Sell? - MarketBeat
Why Bruker (BRKR) Shares Are Plunging Today - Finviz
Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday? - Benzinga
Bruker Corp (BRKR) Shares Down 6.48% on Jan 13 - GuruFocus
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $60 - 富途资讯
Bruker Teases 2026 Margin Surge, $120M Cost Cuts and Double-Digit EPS Growth After Rough 2025 - MarketBeat
Bruker (BRKR) Sets Positive Financial Outlook for 2025 and 2026 - GuruFocus
Bruker (BRKR) Projects Modest Revenue Growth and EPS Increase fo - GuruFocus
Bruker Corp expects 2026 organic revenue growth flat to low-single digits - marketscreener.com
大文字化:
|
ボリューム (24 時間):